OTCMKTS:SARTF - Sartorius Aktiengesellschaft Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 5
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$395.00
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Sartorius Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SARTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SARTF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Sartorius Aktiengesellschaft in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $395.00.
Hold
The current consensus among 5 polled investment analysts is to hold stock in Sartorius Aktiengesellschaft. This rating has held steady since July 2020, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
6/8/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 2 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
11/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/10/2020KeyCorpInitiated CoverageSector Weight
i
10/22/2020DZ BankReiterated RatingSell
i
10/20/2020JPMorgan Chase & Co.Reiterated RatingBuy
i
9/28/2020Berenberg BankReiterated RatingHold
i
9/25/2020JPMorgan Chase & Co.Reiterated RatingBuy
i
7/24/2020DZ BankReiterated RatingSell
i
7/21/2020JPMorgan Chase & Co.Reiterated RatingBuy
i
6/8/2020UBS GroupDowngradeNeutral ➝ Sell
i
4/24/2020DZ BankReiterated RatingSell
i
2/5/2020DZ BankReiterated RatingSell
i
11/22/2019DZ BankReiterated RatingSell
i
10/22/2019DZ BankReiterated RatingSell
i
7/19/2019DZ BankReiterated RatingSell
i
5/15/2019DZ BankReiterated RatingSell
i
4/2/2019DZ BankReiterated RatingSell
i
6/19/2018DZ BankReiterated RatingSell
i
5/3/2018DZ BankReiterated RatingSell
i
2/5/2018DZ BankReiterated RatingSell
i
7/21/2017DZ BankReiterated RatingSell
i
6/2/2017DZ BankReiterated RatingSell
i
3/22/2017DZ BankReiterated RatingNeutral
i
2/1/2017DZ BankReiterated RatingBuy
i
(Data available from 11/29/2015 forward)
Sartorius Aktiengesellschaft logo
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers live cell analysis system, and cell analysis reagents and consumables; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, cannabis testing, food and beverage, environmental, and paint mixing industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Read More

Today's Range

Now: $395.00
$395.00
$395.00

50 Day Range

MA: $368.99
$339.00
$413.10

52 Week Range

Now: $395.00
$190.78
$413.10

Volume

N/A

Average Volume

149 shs

Market Capitalization

$13.51 billion

P/E Ratio

141.58

Dividend Yield

N/A

Beta

0.49